Search the Newsreel

ETFs Investing in Fulcrum Therapeutics, Inc. Stocks

This article lists several ETFs that hold stocks of Fulcrum Therapeutics, Inc. (FULC), a pharmaceuticals company. The list provides details such as market value, weight of FULC in the ETF, issuer, management style, expense ratio, and recent performance for each fund. These ETFs offer …

Fuller, Smith & Turner P.L.C. Class A Revenue Breakdown – LSE:FSTA

EDTK|Skillful Craftsman Education Technology Ltd|Price:0.900|Chg%:-0.082

This article provides a detailed financial overview of Skillful Craftsman Education Technology Ltd (EDTK), including its real-time stock quotes, market trends, and key financial figures. It highlights the company's focus on online vocational education and technology services within the China market. The report also …

FULT|Fulton Financial Corp|Price:24.570|Chg%:+0.310

Fulton Financial Corp (FULT) is currently trading at $24.570, up 1.28%, with a market cap of $4.70B. The company exhibits healthy fundamentals, high growth potential, and is considered fairly valued within the Banking Services industry. Analysts rate it as a "Buy" with a target …

Fulgent Genetics Slips 1.5% as Shares Test Key Support Levels - Protective Put

Full House Resorts Inc (FLL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Full House Resorts Inc (FLL), listing major individual and institutional holders and their respective holdings. It provides quarterly institutional shareholding data showing changes over time, as well as recent shareholder activity by key investors. The report also …

Full House Resorts, Inc. Revenue Breakdown – NASDAQ:FLL

This article provides a revenue breakdown for Full House Resorts Inc (FLL), detailing its business segments and their respective contributions to the total revenue. The main segments include Casino, Food And Beverage, Other Operations, and Hotel, with the Casino segment accounting for the majority …

Full House Resorts Inc (FLL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Full House Resorts Inc (FLL), noting its current valuation score of 8.90 within the Hotels & Entertainment Services industry. It highlights the company's P/E ratio of -2.16, indicating its position relative to recent highs and lows. The …

FULT Q2 Deep Dive: Blue Foundry Integration Drives Growth, Margin Stability Remains Focus

FULT Q2 Deep Dive: Blue Foundry Integration Drives Growth, Margin Stability Remains Focus Regional banking company Fulton Financial (NASDAQ:FULT) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 12% year on year to $367.9 million. Its non-GAAP profit of $0.60 …

Why Is H. B. Fuller (FUL) Down 11% Since Last Earnings Report?

Shares of H. B. Fuller (FUL) have decreased by 11% since its last earnings report, underperforming the S&P 500. Despite this, the company reported strong second-quarter fiscal 2026 results with adjusted earnings up 19% year-over-year and revenues exceeding estimates, driven by pricing and currency …

FLL|Full House Resorts Inc|Price:2.400|Chg%:+0.040

Full House Resorts Inc. (FLL) is trading at $2.335 USD, down 2.30%, with a market cap of $84.60M. TradingKey's stock score indicates stable fundamentals, significant growth potential, and a fair valuation, though institutional ownership is high and stock market performance has been weak. Despite …

Fulton Financial (FULT) Stock Faces Flat EPS As Strong Net Interest Margin Supports Bull Narratives

Fulgent Genetics (FLGT) to Release Earnings on Thursday

Fulgent Genetics (FLGT) is scheduled to release its Q2 2026 earnings before market open on Thursday, July 30th, with analysts anticipating a loss of $0.46 per share on revenues of $94.0 million. Wall Street maintains a "Hold" rating for FLGT with a consensus price …

Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for potential securities law violations. This investigation follows Fulcrum's announcement on June 1, 2026, of the discontinuation of its pociredir program for sickle cell disease due to FDA concerns regarding the drug's …

Fulton Financial (FULT) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, Fulton Financial (FULT) reported revenue of $367.87 million, up 12% over the same period last year. EPS came in at $0.60, compared to $0.55 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Fulton Financial’s (NASDAQ:FULT) Q2 CY2026 Sales Top Estimates

Fulton Financial's (NASDAQ:FULT) Q2 CY2026 Sales Top Estimates Regional banking company Fulton Financial (NASDAQ:FULT) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 12% year on year to $367.9 million. Its non-GAAP profit of $0.60 per share was 12.6% above analysts' consensus …

FULTON FINANCIAL ($FULT) Releases Q2 2026 Earnings

Fulton Financial Corporation Announces Second Quarter 2026 Results

LANCASTER, Pa., July 22, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ: FULT) ("Fulton" or the "Corporation") reported net income available to common shareholders of $99.9 million, or $0.52 per diluted share, for the second quarter of 2026, an increase of $7.7 million, or $0.01 …

YMM or SYM: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Technology Services sector might want to consider either Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) or Symbotic Inc. (SYM). But which of these two stocks is more attractive to value investors? We'll need to take a closer …

How (YMM) Movements Inform Risk Allocation Models

This article analyzes Full Truck Alliance Co. Ltd. (NYSE: YMM) using AI models, highlighting strong near and mid-term sentiment but a weak long-term outlook. It identifies compelling upside potential due to a lack of resistance levels above the current price. The report also outlines …

Fulton Financial (FULT) Surpasses Q2 Earnings and Revenue Estimates

Kaplan Fox Announces an Investigation Into Fulcrum Therapeutics

Kaplan Fox & Kilsheimer LLP has initiated an investigation into Fulcrum Therapeutics, Inc. (NASDAQ: FULC) regarding potential securities law violations. This follows a significant drop in Fulcrum's stock price after the company announced the discontinuation of its pociredir program for sickle cell disease due …

FULTON FINANCIAL CORPORATION APPOINTS DAVID S. SCHULZ TO BOARD OF DIRECTORS

LANCASTER, Pa., July 21, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ: FULT) ("Fulton") today announced the appointment of David S. Schulz as a member of its board of directors (the "Board") for a term commencing September 14, 2026 and expiring at Fulton's 2027 annual …

H.B. Fuller (FUL) Could Be 24% Below Fair Value On Credit Refinancing

H.B. Fuller (FUL) recently refinanced its credit agreement, extending maturities and lowering interest margins, yet its share price has fallen. Despite this, the company is estimated to be 24.4% undervalued, trading at $55.43 against a fair value of $73.29, according to analyst consensus and …

Form 4 Fulcrum Therapeutics Inc For: 21 July By Investing.com

This article reports on a Form 4 filing for Fulcrum Therapeutics Inc. dated July 21st, 2026. Form 4 filings typically disclose transactions by company insiders, however, the content beyond the headline is minimal, indicating this islikely an automated news brief. The article notes a …

5 Value Stocks With Impressive EV-to-EBITDA Ratios to Own Now

This article highlights the EV-to-EBITDA ratio as a superior valuation metric compared to the P/E ratio, especially for identifying undervalued companies or potential acquisition targets. It explains why EV-to-EBITDA provides a clearer view of a company's financial health, accounting for debt and non-cash expenses. …

Fulcrum Therapeutics: director Kevin Tang buys $594k in shares

Kevin Tang, a director and 10% owner of Fulcrum Therapeutics, recently purchased 167,616 shares worth approximately $594,675 over two days in mid-July 2026. This insider buying occurs as FULC stock is significantly down year-to-date and below its 52-week high, following the discontinuation of its …

H. B. Fuller Company (NYSE:FUL) Receives Average Rating of "Moderate Buy" from Analysts

Fulton Financial (FULT) To Report Earnings Tomorrow: Here Is What To Expect

Fulton Financial (FULT) To Report Earnings Tomorrow: Here Is What To Expect Regional banking company Fulton Financial (NASDAQ:FULT) will be reporting earnings this Wednesday after market hours. Here's what to look for. Fulton Financial met analysts' revenue expectations last quarter, reporting revenues of $336.2 …

Fulcrum Therapeutics, Inc. (FULC) insider funds purchase 167,616 shares at ~$3.5

Kevin Tang and affiliated Tang Capital entities, identified as 10% owners of Fulcrum Therapeutics (FULC), indirectly purchased 167,616 shares of common stock on July 16–17, 2026. The shares were acquired at weighted-average prices of $3.56 and $3.52 per share, falling within a trade range …

Fulcrum Therapeutics 10% owner Kevin Tang acquires $594,132 of common shares

Kevin Tang, a 10% owner of Fulcrum Therapeutics through Tang Capital-managed entities, reportedly acquired common shares worth $594,132. The shares were purchased at prices ranging from $3.52 to $3.56, increasing his beneficial ownership to 7,080,945 shares. This information originated from a disclosure filed with …

CFO John Corkrean awarded 221 phantom units at FULLER H B CO (FUL)

John J. Corkrean, Executive VP and CFO of FULLER H B CO (FUL), was granted 221.27 phantom units on July 17, 2026, valued at $56.96 per unit as part of the Key Employee Deferred Compensation Plan. These units, which include dividend equivalents, convert to …

H.B. Fuller Company (NYSE: FUL) extends $800M credit line to 2031

H.B. Fuller Company has refinanced and extended its senior credit facilities, increasing its revolving credit facility to $800 million and extending the maturity of these facilities to July 17, 2031. The amendment also reduces applicable interest rate margins by 25 basis points and led …

H.B. Fuller amends credit agreement, extends $420 million term loan A and $800 million revolver to 2031

H.B. Fuller has amended its February 2023 credit agreement with JPMorgan Chase, effectively refinancing its term A loans at $420 million and its revolving loans at $700 million. The company also increased lender commitments by $100 million, bringing the total revolving facility to $800 …

H.B. Fuller Extends Credit Facility to 2031, Ups Revolver to $800 Million, Lowers Margins

H.B. Fuller (FUL) has amended its senior credit agreement, extending maturities to July 17, 2031, and increasing its revolving credit facility to $800 million, while also reducing interest margins by 25 basis points. Concurrently, the company terminated a $2.09 billion secured bridge credit agreement …

Bessemer Group Inc. Raises Position in H. B. Fuller Company $FUL

Bessemer Group Inc. significantly increased its stake in H. B. Fuller Company (NYSE:FUL) by 30.8% in the first quarter, now holding 130,110 shares valued at approximately $8.0 million. This comes as H. B. Fuller reported strong quarterly results, exceeding analyst expectations with an EPS …